Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Tau Kinetics in Neurons and the Human Central Nervous System.

Neuron | 2018

We developed stable isotope labeling and mass spectrometry approaches to measure the kinetics of multiple isoforms and fragments of tau in the human central nervous system (CNS) and in human induced pluripotent stem cell (iPSC)-derived neurons. Newly synthesized tau is truncated and released from human neurons in 3 days. Although most tau proteins have similar turnover, 4R tau isoforms and phosphorylated forms of tau exhibit faster turnover rates, suggesting unique processing of these forms that may have independent biological activities. The half-life of tau in control human iPSC-derived neurons is 6.74 ± 0.45 days and in human CNS is 23 ± 6.4 days. In cognitively normal and Alzheimer's disease participants, the production rate of tau positively correlates with the amount of amyloid plaques, indicating a biological link between amyloid plaques and tau physiology.

Pubmed ID: 29566794 RIS Download

Associated grants

  • Agency: NIA NIH HHS, United States
    Id: K01 AG053474
  • Agency: NIA NIH HHS, United States
    Id: P01 AG003991
  • Agency: NIA NIH HHS, United States
    Id: P50 AG005681
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK056341
  • Agency: NIA NIH HHS, United States
    Id: P01 AG026276
  • Agency: NIGMS NIH HHS, United States
    Id: P41 GM103422
  • Agency: NINDS NIH HHS, United States
    Id: P30 NS098577
  • Agency: NIA NIH HHS, United States
    Id: K01 AG046374
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS078398
  • Agency: NINDS NIH HHS, United States
    Id: P30 NS048056
  • Agency: NCATS NIH HHS, United States
    Id: UL1 TR000448
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS095773
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK020579
  • Agency: NCATS NIH HHS, United States
    Id: UL1 TR002345

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Anti-alpha smooth muscle Actin antibody (antibody)

RRID:AB_2223021

This polyclonal targets alpha smooth muscle Actin

View all literature mentions

Nanog Polyclonal Antibody (antibody)

RRID:AB_2150115

This unknown targets Nanog

View all literature mentions

Tau7 (antibody)

RRID:AB_2721195

This monoclonal targets Tau protein

View all literature mentions

HJ9.1 (antibody)

RRID:AB_2721236

This monoclonal targets tau

View all literature mentions

HJ9.3 (antibody)

RRID:AB_2721235

This monoclonal targets tau

View all literature mentions

Tau5 (antibody)

RRID:AB_2721194

This monoclonal targets Tau protein

View all literature mentions

Tau1 (antibody)

RRID:AB_2721197

This monoclonal targets Tau protein

View all literature mentions

HJ8.7 (antibody)

RRID:AB_2721234

This monoclonal targets tau

View all literature mentions

HJ8.5 (antibody)

RRID:AB_2721237

This monoclonal targets tau

View all literature mentions

Tau13 (antibody)

RRID:AB_2721193

This monoclonal targets tau

View all literature mentions

Tau12 (antibody)

RRID:AB_2721192

This monoclonal targets tau

View all literature mentions